There are many cellular pathways that regulate lifespan and healthy aging. Here, we investigate a novel pathway, bioactive sphingolipid metabolism, and its interactions in known aging genes. Sphingolipids are involved in cell proliferation, secretion, stress response and survival. The sphingolipid pathway is composed of sphingomyelin, ceramide, sphingosine and sphingosine-1-phosphate (S1P) and interconverted by metabolic enzymes. Ceramide synthases (CER synthases) mediate the conversion of sphingosine to ceramide whereas sphingosine kinase (SPHK) converts sphingosine to S1P. Previously, our lab found that mutations in worm
sphk-1/SPHK result in decreased lifespan, suggesting that sphingolipids play a role in lifespan regulation. However, other sphingolipid genes are largely unexplored. Therefore, we tested the genetic interactions between sphingolipid enzymes and known models of aging, including the insulin like signaling (ILS) pathway and mechanistic target of rapamycin (mTOR) caloric restriction pathways that have been linked to lifespan extension. For this, lifespan analyses were performed on
sphk-1/SPHK and
hyl-2/CER synthase mutants in a
daf-16/FOXO background, to determine epistatic interactions. We observed that
daf-16 is epistatic to sphingolipid mutants for lifespan phenotypes, as indicated by similar short lifespan phenotypes of double knockout of
daf-16;
hyl-2 and
daf-16;
sphk-1mutants with a single
daf-16 mutant. Thus, sphingolipids may act upstream of DAF-16 to mediate lifespan.To further test this, we will examine whethersphk-1or
hyl-2mediate cellular stress response using transcriptional reporters for known stress response genes (SOD-3/superoxide dismutase) or translation reporters for DAF-16 nuclear transport. Furthermore, we will examine whether RNAi knock down of sphingolipid metabolism genes affects lifespan in long-lived mutants, including
eat-2/mACh,
daf-2/insulin-like growth factor receptor, andclk-1/CDC like kinase 1 mutants. Theexamination of sphingolipids pathways in lifespan and stress response will further enhance our understanding of the interaction between sphingolipids and known pathways that promote lifespan and healthspan.